chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PT became dizzy and had a seizure like response with LOC and tonic/clonic activity only lasting 2-3 seconds. PT spontaneously woke up and was mildly confused. BP 143/93 other vitals stable
Doctor though was an allergy; rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear; Redness on left side of nose; Nausea; Fever; Dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Solitary kidney.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nausea) and PYREXIA (Fever). On 01-May-2021, the patient experienced ERYTHEMA (Redness on left side of nose). On an unknown date, the patient experienced HYPERSENSITIVITY (Doctor though was an allergy) and RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medications was provided.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments.
The under arm pit swelling and pain; The under arm pit swelling and pain; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot Number: EN6205) (at the age of 46 years) as dose number unknown, single for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications included unspecified vitamins. The patient experienced under arm pit swelling and pain on an unspecified date with outcome of unknown. Patient just got the shot on Sunday (unspecified date in 2021) and read that it was common. Patient called the doctor she said wait for a week because she has rheumatoid arthritis, so she said wait because some people with rheumatoid arthritis end up with the swollen armpit gland. So, she said just waited a little bit, just took Tylenol. The outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
A report has been received from a Health Professional concerning a 13 year old, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 28-Sep-2013. The patient experienced RASH ALL OVER BODY which started on 02-Oct-2013. The outcome of the event of RASH ALL OVER BODY is unknown. The report was considered to be non-serious.
Experienced blisters after administration; This is a spontaneous report from a contactable pharmacist via Pfizer Sales Representative.   A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration, on an unspecified date at single dose for immunisation . The patient medical history and concomitant medications were not reported. The patient experienced blisters after administration, on an unspecified date. The outcome of the event was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
Bilat nares developed blistering that progressed to facial rash on nose and around eyes.
Sore arm at injection site.  Soreness included sore to touch and muscle pain when lifting arm.  Duration 2 days.
Dose #2 - Nose bleeds following the 2nd Pfizer COVID-19 vaccine beginning a few days later and lasting at least (1) one week; on 2/2/2021 this patient coughed up a pea-sized bright red blood clot; no blood clots noted since that one time and no petechiae noted; severe body and joint aches and pain beginning the next day and lasting 24 hours. No fever noted on any day.  Dose #1 - Nausea / diarrhea beginning a few days later and lasting two and one-half (2 1/2) weeks; sore arm same day and lasting at least 3 days. No fever noted on any day.
tested positive for Covid; This is a spontaneous report from contactable consumer. This consumer reported for a 52-year-old male patient (reporter's husband). A 52-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6200, expiration date: unknown ) an unspecified route of administration in right arm on 04Mar2021 as SINGLE DOSE for covid-19 immunization. The patient had no medical history and concomitant medications were not reported. The consumer reported that she and her husband received the vaccine on 04Mar2021, clarified as Pfizer Covid-19 vaccine. And stated that her husband woke up with a scratchy throat on thursday but did not think anything of it because moved to a new house surrounded by trees and allergies some days. A lot of mango trees around them. However, apparently he was coming down with COVID. Her husband tested positive for Covid on Monday, 08Mar2021 and that she tested positive for Covid on Tuesday, 09Mar2021. She reported that her husband began to have body aches and headaches on Monday, 08Mar2021. She stated that he began to have all of the normal Covid symptoms, clarified as congestion, cold/flu like symptoms. The body aches started sunday evening and she believes they had resolved completely by tuesday morning as her husband didn't say anything about them. She reported that the headache lasted maybe a day and that she doesn't think it was much of a headache. Her husband just had a little bit of a cough, like a single cough and runny nose resolved when the congestion began. She reported that her husband had stated that he can taste some sweets but can't taste much of anything else. She reported that she believes that the symptoms of not being able to smell or taste have remained the same. Tested positive for covid: The consumer reported that her husband is feeling better already, but he still can't smell or taste anything. She also said that her husband took Tylenol and that one night, either Monday 08Mar2021 or Tuesday 09Mar2021, he took Nyquil. Caller reported that her husband probably took the Nyquil on Monday, 08Mar2021. She stated that it helped his symptoms. The event considered non-serious by the reporter. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 08Mar2021. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
patient came in 5/18/21 for her second dose that informed me that she miscarried 5 days after receiving her first dose of the Pfizer vaccine on 4/27/21.
Hospitalization for Neck malignancy, beer potomania, asymptomatic COVID-pneumonia  on dates 7/18/2023-7/20/2023. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
The morning following injection patient reports increased temp 101 with body aches. Day 2-Body aches and tenderness in Rt axilla. Day 3-Pain Rt axilla extending to Rt breast and she reports swelling under axilla also.
30 minutes after receiving vaccine, felt like electric shocks in the head (two to three times). It stopped in the evening but got constant low headaches afterwards. Around 5pm, felt like a change in taste (saltier taste) that was temporary. Has uncomfortable wrist pain like twisting a screwdriver too much. Started feeling itchy today after 9 am. Face was swollen after waking up today and has subsided greatly since. Had very low fever last night and now feels like no fever. Right now, feeling has a lot of saliva and then have to swallow and little uncomfortable in arms and knees, and weakness. Only took one Aleve pill last night. Around 4:30pm, felt a little blurry for 5 to 10 seconds.
Fever to 102, nausea/vomiting, fussiness, papular rash on feet (now generalized), localized vesicular rash/induration/erythema/tenderness at injection site.
Elevated Blood Pressure, Body aches, radiating pain throughout the entire body, numbness on the left side of the body from shoulder to foot, headaches, loss of appetite, blurred vision, fatigue, throat pain
pt recv vax & devel inj site rxn characterized by a fist-sized area of erythema, swelling & tenderness;pt was treated w/ice & recovered;
Psoriatic arthritis aggravated; Rheumatoid arthritis flare up; This is a solicited report based on the information received by Pfizer, (Mfr. Control No.: 21K-163-3918137-00). A non-contactable consumer (patient) reported that solicited report from the (country) by a consumer of a 63 year old female with events of Flare up of psoriatic and rheumatoid arthritis with humira (Adalimumab). PFIZER BIONTECH COVID-19 VACCINE (TOZINAMERAN) was also considered suspect. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. In 2021, patient received 1st dose COVID-19 Vaccine manufactured by Pfizer. On 13Apr2021, patient received 2nd dose COVID-19 Vaccine manufactured by Pfizer. A 63-years-old female patient received bnt162b2, dose 2 via intramuscular on 13Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation; adalimumab (HUMIRA), via subcutaneous from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for psoriatic arthritis and moderate to severe rheumatoid arthritis. There was no reported medical history. The patient's concomitant medications were not reported. Historical vaccine included 1st dose of BNT162B2 in 2021 for COVID-19 immunization. In 2021, the patient experienced flare up of psoriatic and rheumatoid arthritis. In 2021, the flare up of psoriatic and rheumatoid arthritis resolved. The patient was treated with Prednisone.  Causality for adalimumab: The reporter's causality for the events of flare up of psoriatic and rheumatoid arthritis onset in 2021 and flare up of psoriatic and rheumatoid arthritis onset in 2021 with humira (adalimumab) was no reasonable possibility.  The reporter's assessment of the causal relationship of the events with the suspect product bnt162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  No follow-up attempts are possible. No further information is expected. Information about batch number cannot be obtained.; Sender's Comments: Based on the narrative information provided, there is no reasonable possibility that the reported event Rheumatoid arthritis and Psoriatic arthropathy is related to BNT162B2 (COVID-19 mRNA VACCINE).
pt recvd vax & had red; slightly raised area; 8cm in diam; warm to touch;
Full dose is administered for a booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Full dose is administered for a booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Full dose is administered for a booster). At the time of the report, ACCIDENTAL OVERDOSE (Full dose is administered for a booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.
Pain, / in the arm (site of injection); swollen / in the arm (site of injection); redness in the arm (site of injection); general discomfort.; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced injection site pain, injection site swelling, injection site erythema and general discomfort. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema and general discomfort were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema and general discomfort to be related to Bexsero.  Additional details were reported as follows: The age at vaccination was not reported. Nurse informed that after the vaccination of patient with Bexsero, the patient experienced pain, swollen, redness in the arm (site of injection) and general discomfort. The reporter consented to follow up. This case is 1 of the 13 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR209822:same reporter US-GLAXOSMITHKLINE-US2020AMR210163:same reporter US-GLAXOSMITHKLINE-US2020AMR210159:same reporter US-GLAXOSMITHKLINE-US2020AMR210164:same reporter US-GLAXOSMITHKLINE-US2020AMR210162:same reporter US-GLAXOSMITHKLINE-US2020AMR210157:same reporter US-GLAXOSMITHKLINE-US2020AMR210160:same reporter US-GLAXOSMITHKLINE-US2020AMR210161:same reporter US-GLAXOSMITHKLINE-US2020208660:same reporter US-GLAXOSMITHKLINE-US2020AMR210158:same reporter US-GLAXOSMITHKLINE-US2020AMR210166:same reporter US-GLAXOSMITHKLINE-US2020AMR210156:same reporter
Very tender, sore, and unable to close my arm; pain at injection site is high; lymph nodes under my left arm pit are the size of a baseball./lymph node enlargement; Very tender, sore, and unable to close my arm; unable to close my arm.; This is a spontaneous report from a contactable other health care professional (patient). A 55-years-old male patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: FF2587, expiry date: not reported) via an unspecified route of administration, administered in Arm Left on 05Oct2021 14:15 (at age 55-years-old) of as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation in doctor's office/urgent care. Medical history included Strawberries, Apples allergy (known allergies: strawberries, apples), high lipids, kidney stones, hyperhidrosis. Concomitant medication(s) included allopurinol (ALLOPURINOL); omega-3-acid ethyl ester (LOVAZA) and atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported.The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0158, expiry date: not reported) via an unspecified route of administration, administered in Arm Left on 07Apr2021 10:30 as DOSE 1, SINGLE for covid-19 immunisation and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0175, expiry date: not reported) via an unspecified route of administration, administered in Arm Left on 28Apr2021 11:00 as DOSE 2, SINGLE for covid-19 immunisation.Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.On 05Oct2021 19:30, lymph nodes under my left arm pit are the size of a baseball. Very tender, sore, and unable to close my arm. Also, pain at injection site is high, but the lymph node enlargement was the reason for concern. No treatment was received. No prolonged hospitalization was reported. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Sep2021. The outcome of events was not recovered. No follow-up attempts are possible. No further information is expected.
Pt exp 10 days of nasal congestion; devel fever 101 R, fussy, scattered rhonchi in lungs; pt given ATB to cover for poss bacterial infect; pt exp hoarseness w/cough; given ATB for poss croup; became lethargic & limp; dx URI-viral synd;
19JUN92 8PM mom relates pt felt hot did not take temp; 20JUN92 8AM felt very hot to touch APAP given; pt vomited back up x 1; to ER 330PM 20AUG adm to hosp 430PM;
Alice In Wonderland Syndrome - visual and perceptual/proprioceptive distortions. Non-vestibular.
Severe rash outbreak on feet, wrist, legs, arms, and back along with itching.  Was prescribed corticoid steroid creams to treat, which eased up a bit.
The vial was initially stored in the refrigerator and administered after its beyond use by date of 30-Nov-2022; No adverse event; Patient received an expired first primary dose after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired first primary dose after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator and administered after its beyond use by date of 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired first primary dose after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator and administered after its beyond use by date of 30-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired first primary dose after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator and administered after its beyond use by date of 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received an expired first primary dose after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator and administered after its beyond use by date of 30-Nov-2022).    No concomitant medication information was reported.  The vial size was 2.5 mL.     The date on which the vial was initially stored in the refrigerator was unknown but beyond use by date was on 30-Nov-2022.  The vial did not undergo any temperature excursions.  No treatment information was reported.
This spontaneous report as received from a pharmacist, refers to unspecified patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, three unspecified patients were vaccinated with improperly stored (exposed to 11 Fahrenheit (F) for 15.5 hours) ZOSTAVAX, 0.65 ml once, subcutaneous (strength and lot number or batch number unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. The outcome of the event was unknown. No further information was provided. Additional information has been requested.
Injection site red/rash. Vomit/diarrhea/throbbing HA.
feel sleepy; headache; Three hours after administrating the 1st dose on my left arm, the whole arm suffered a big pain; some numbness on the left hand; could not move the arm at all because of the pain; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, solution for injection, Batch/Lot number: EL3247), via an unspecified route of administration, administered in left arm on 24Feb2021 at 10:00 as a single dose for covid-19 immunization. The patient's medical history included DCIS on left breast. The patient's concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other medications in four weeks. The patient had no COVID prior to vaccination and was not COVID tested post vaccination. On 24Feb2021 at 13:00, three hours after administrating the 1st dose on left arm, the whole arm suffered a big pain and there was even some numbness on the left hand. The patient could not move the arm at all because of the pain. Six hours after administrating, on 24Feb2021 at 16:00 hours, the patient started to feel sleepy and have headache. The patient did not receive any treatment for the adverse events. The outcome for the events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
out for the count this weekend; the one who administered the vaccine must have dripped or dropped some of the contents of the syringe, was reporting in case of dosage, and he suspected some of it spilled; This is a spontaneous report from a contactable consumer from Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (COMIRNATY, formulation: solution for injection, batch/lot number: unknown) via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. Caller stated that getting the second shot today of the Pfizer Biontech COVID-19 vaccine and reports the one who administered the vaccine must have dripped or dropped some of the contents of the syringe, was reporting in case of dosage, and he suspected some of it spilled. Caller declined to complete report on his wife at this time, says he will see if he gets sick, says lets keep that separate. Caller states his wife received the same Pfizer vaccine. The patient experienced out for the count this weekend on an unspecified date. The outcome of event was unknown.    Information about batch/lot number has been requested. Further information was expected.